MedCords Secures ₹53.6 Lakh in Series A Funding to Revolutionize India’s Healthcare Network

MedCords, a dynamic healthcare network beyond the ordinary, is thrilled to announce a significant funding milestone of 5,360,000. This investment comes as a strong endorsement of MedCords’ innovative approach to revolutionizing healthcare in India. By seamlessly enabling offline chemists to go online, MedCords is dismantling the traditional barriers of retailing and extending quality healthcare to communities across the country. With its triad of apps—Aayu, Aayu Chemist, and Aayu Doctor—the company is committed to the credo "Jab Baat Ho Health Ki," ensuring that every citizen across Bharat has swift access to healthcare services. The robust network already spans 17 states, connecting a family of over 40,000 chemists, 5,000 specialist doctors, and serving a growing customer base of 3.5 million. This new injection of capital is earmarked to further strengthen the company’s operations and expand its reach nationwide. It will fuel strategic initiatives to enhance digital infrastructure, drive technology integration for secure medical data sharing, and optimize the delivery of services such as rapid medicine delivery within two hours, on-demand doctor's consultations, and at-home lab tests from a selection of more than 160 tests. Backed by prominent investors including Infoedge, Waterbridge, Astrac, RVCF, US-based Village Global (Personal Fund of Bill Gates), Earls-Field, Director Policy Bazaar, Founders of No Broker, and Anand Chandrasekaran, MedCords is poised to redefine healthcare accessibility. This funding not only serves as a vote of confidence in the company’s business model but also as a catalyst to propel its mission of making high-quality healthcare easily accessible to every Indian home.